Motco Organon & Co. Transaction History

Motco

$991 Million
Q3 2024

A detailed history of Motco transactions in Organon & Co. stock. As of the latest transaction made, Motco holds 8 shares of OGN stock, worth $119. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 8 -0.0%

Holding current value

$119

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$17.45 - $21.96 $52 - $65	-3 Reduced 27.27%	8 $0
Q4 2023 Feb 09, 2024	SELL	$10.95 - $17.32 $54 - $86	-5 Reduced 31.25%	11 $0
Q3 2023 Nov 07, 2023	SELL	$16.59 - $23.77 $331 - $475	-20 Reduced 55.56%	16 $0
Q2 2023 Aug 04, 2023	BUY	$19.27 - $24.63 $289 - $369	15 Added 71.43%	36 $0
Q1 2023 May 09, 2023	BUY	$21.42 - $32.08 $107 - $160	5 Added 31.25%	21 $0
Q4 2022 Feb 10, 2023	SELL	$23.31 - $28.61 $2,703 - $3,318	-116 Reduced 87.88%	16 $0
Q3 2022 Nov 03, 2022	SELL	$23.4 - $34.25 $18,064 - $26,441	-772 Reduced 85.4%	132 $3,000
Q1 2022 May 06, 2022	BUY	$30.45 - $39.36 $1,431 - $1,849	47 Added 5.48%	904 $32,000
Q3 2021 Oct 29, 2021	SELL	$28.63 - $35.64 $481,327 - $599,179	-16,812 Reduced 95.15%	857 $28,000
Q2 2021 Aug 04, 2021	BUY	$28.45 - $38.0 $502,683 - $671,422	17,669 New	17,669 $535,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$485 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$449 Million
0.01% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$145 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$134 Million
0.01% of portfolio
Lsv Asset Management Chicago, IL

7.49M
Shares

$112 Million
0.31% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.

Account